HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.

AbstractOBJECTIVE:
The coronavirus disease 2019 (COVID-19) has rapidly developed into a pandemic. Increased levels of ferritin due to cytokine storm and secondary hemophagocytic lymphohistiocytosis were found in severe COVID-19 patients. Therefore, the aim of this study was to determine the role of ferritin in COVID-19.
METHODS:
Studies investigating ferritin in COVID-19 were collected from PubMed, EMBASE, CNKI, SinoMed, and WANFANG. A meta-analysis was performed to compare the ferritin level between different patient groups: non-survivors versus survivors; more severe versus less severe; with comorbidity versus without comorbidity; ICU versus non-ICU; with mechanical ventilation versus without mechanical ventilation.
RESULTS:
A total of 52 records involving 10 614 COVID-19-confirmed patients between December 25, 2019, and June 1, 2020, were included in this meta-analysis, and 18 studies were included in the qualitative synthesis. The ferritin level was significantly increased in severe patients compared with the level in non-severe patients [WMD 397.77 (95% CI 306.51-489.02), P < .001]. Non-survivors had a significantly higher ferritin level compared with the one in survivors [WMD 677.17 (95% CI 391.01-963.33), P < .001]. Patients with one or more comorbidities including diabetes, thrombotic complication, and cancer had significantly higher levels of ferritin than those without (P < .01). Severe acute liver injury was significantly associated with high levels of ferritin, and its level was associated with intensive supportive care, including ICU transfer and mechanical ventilation.
CONCLUSIONS:
Ferritin was associated with poor prognosis and could predict the worsening of COVID-19 patients.
AuthorsLinlin Cheng, Haolong Li, Liubing Li, Chenxi Liu, Songxin Yan, Haizhen Chen, Yongzhe Li
JournalJournal of clinical laboratory analysis (J Clin Lab Anal) Vol. 34 Issue 10 Pg. e23618 (Oct 2020) ISSN: 1098-2825 [Electronic] United States
PMID33078400 (Publication Type: Journal Article, Meta-Analysis, Systematic Review)
Copyright© 2020 The Authors. Journal of Clinical Laboratory Analysis Published by Wiley Periodicals LLC.
Chemical References
  • Ferritins
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Betacoronavirus
  • COVID-19
  • Comorbidity
  • Coronavirus Infections (blood, diagnosis, epidemiology, mortality)
  • Female
  • Ferritins (blood)
  • Humans
  • Male
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral (blood, diagnosis, epidemiology, mortality)
  • Prognosis
  • SARS-CoV-2

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: